Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to Ascentage Pharma on the offering, and Davis Polk & Wardwell advised the underwriters....
Ascentage Pharma’s $126.4 Million Initial Public Offering and Nasdaq Listing
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
Stoke Therapeutics’ $125 Million Upsized Common Stock Offering
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
MSCI’s Acquisition of Foxberry
Davis Polk & Wardwell advised MSCI Inc. on the transaction. MSCI Inc. (NYSE: MCI) announced the acquisition of Foxberry, a London based provider of front-office index...
Immatics’ $201 Million Follow-On Offering
Davis Polk & Wardwell advised Immatics N.V. on the offering, and Covington & Burling advised the underwriters. Immatics N.V. (Nasdaq: IMTX) announced its $201 million SEC-registered offering...
MSCI’s Acquisition of Fabric
Davis Polk advising MSCI Inc., while Dechert is advising Fabric on the deal. Fabric, a wealth technology platform specializing in portfolio design, customization, and analytics for...
Smith+Nephew’s $330 Million Acquisition of CartiHeal
Davis Polk & Wardwell is advising Smith+Nephew on the transaction. Smith+Nephew (NYSE:SNN) announced it has entered into a definitive agreement of CartiHeal. Under the terms of the...
Newfold Digital Holdings Group’s $515 Million Secured Notes Offering
Davis Polk & Wardwell advised the initial purchasers on the offering. Newfold Digital Holdings Group, Inc. announced its Rule 144A / Regulation S offering valued at $515 million...
Immedica Pharma’s Acquisition of Pegzilarginase Assets from Aeglea
Davis Polk & Wardwell advised Immedica Pharma AB on the transaction. Immedica Pharma AB announced its acquisition from Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) of all assets related...
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
Oculis Holding’s $40.25 Million Debut Equity Offering
Davis Polk advised BofA Securities, Inc., SVB Securities LLC on the offering. Cooley LLP represented Oculis Holding in the offering. Vischer AG advised Oculis Holding for...
Seagate’s $1 Billion Senior Notes Offering
Wilson Sonsini advised Seagate on the offering, while Davis Polk advised Morgan Stanley & Co. LLC. Seagate HDD Cayman (the “Company”), a subsidiary of Seagate Technology...